Cargando…

Infections and Immunotherapy in Lung Cancer: A Bad Relationship?

Infectious diseases represent a relevant issue in lung cancer patients. Bacterial and viral infections might influence the patients’ prognosis, both directly affecting the immune system and indirectly impairing the outcome of anticancer treatments, mainly immunotherapy. In this analysis, we aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Belluomini, Lorenzo, Caldart, Alberto, Avancini, Alice, Dodi, Alessandra, Trestini, Ilaria, Kadrija, Dzenete, Sposito, Marco, Tregnago, Daniela, Casali, Miriam, Riva, Silvia Teresa, Sartori, Giulia, Menis, Jessica, Milella, Michele, Pilotto, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793072/ https://www.ncbi.nlm.nih.gov/pubmed/33375194 http://dx.doi.org/10.3390/ijms22010042

Ejemplares similares

A narrative review on tumor microenvironment in oligometastatic and oligoprogressive non-small cell lung cancer: a lot remains to be done
por: Belluomini, Lorenzo, et al.
Publicado: (2021)

Body composition as a modulator of response to immunotherapy in lung cancer: time to deal with it
por: Trestini, I., et al.
Publicado: (2021)

Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned
por: Belluomini, Lorenzo, et al.
Publicado: (2021)

Willingness, preferences, barriers, and facilitators of a multimodal supportive care intervention including exercise, nutritional and psychological approach in patients with cancer: a cross-sectional study
por: Avancini, Alice, et al.
Publicado: (2022)

Adjuvant Targeted Therapy in Solid Cancers: Pioneers and New Glories
por: Sposito, Marco, et al.
Publicado: (2023)

Evaluation of nutritional status in non-small-cell lung cancer: screening, assessment and correlation with treatment outcome
por: Trestini, Ilaria, et al.
Publicado: (2020)

Physical Activity and Exercise in Lung Cancer Care: Will Promises Be Fulfilled?
por: Avancini, Alice, et al.
Publicado: (2019)

Exercise and Bone Health in Cancer: Enemy or Ally?
por: Avancini, Alice, et al.
Publicado: (2022)

Development of Educational Print Materials for Physical Activity in Cancer: Evaluation of Readability and Suitability
por: Avancini, Alice, et al.
Publicado: (2021)

1640P Impact of COVID-19 vaccination campaign on psychological status in cancer patients (pts)
por: Tregnago, D., et al.
Publicado: (2021)

Factors Influencing Physical Activity in Cancer Patients During Oncological Treatments: A Qualitative Study
por: Avancini, Alice, et al.
Publicado: (2020)

Physical Activity for Oncological Patients in COVID-19 Era: No Time to Relax
por: Avancini, Alice, et al.
Publicado: (2020)

Unlocking New Horizons in Small-Cell Lung Cancer Treatment: The Onset of Antibody–Drug Conjugates
por: Belluomini, Lorenzo, et al.
Publicado: (2023)

Multidisciplinary lifestyle intervention to manage pancreatic cancer-related cachexia: a case report
por: Avancini, Alice, et al.
Publicado: (2020)

Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma
por: Trestini, Ilaria, et al.
Publicado: (2021)

1430P Psychological status and patient perception during the SARS-CoV-2 vaccination campaign in active oncological patients (pts)
por: Daniela, T., et al.
Publicado: (2022)

Exercise Levels and Preferences in Cancer Patients: A Cross-Sectional Study
por: Avancini, Alice, et al.
Publicado: (2020)

Effect of exercise across the head and neck cancer continuum: a systematic review of randomized controlled trials
por: Avancini, Alice, et al.
Publicado: (2023)

Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic
por: Zuliani, Serena, et al.
Publicado: (2020)

“Running with cancer”: A qualitative study to evaluate barriers and motivations in running for female oncological patients
por: Avancini, Alice, et al.
Publicado: (2020)

1701P Oncological patients’ perception of infection risks and level of acceptance of protective measures during SARS-CoV-2 pandemic
por: Tregnago, D., et al.
Publicado: (2020)

Evidence-based tailored nutrition educational intervention improves adherence to dietary guidelines, anthropometric measures and serum metabolic biomarkers in early-stage breast cancer patients: A prospective interventional study
por: Trestini, Ilaria, et al.
Publicado: (2021)

SCLC Treatment in the Immuno-Oncology Era: Current Evidence and Unmet Needs
por: Belluomini, Lorenzo, et al.
Publicado: (2022)

Long-term survivors with immunotherapy in advanced NSCLC: is ‘cure’ within reach?
por: Monteverdi, Sara, et al.
Publicado: (2020)

Multicentre, randomised, open-label, parallel-group, clinical phase II study to evaluate immunonutrition in improving efficacy of immunotherapy in patients with metastatic non-small cell lung cancer, undergoing systematic nutritional counseling
por: Caccialanza, Riccardo, et al.
Publicado: (2022)

Psychological impact of Covid-19 pandemic on oncological patients: A survey in Northern Italy
por: Pigozzi, Eva, et al.
Publicado: (2021)

1723P Organizational challenges and oncological activity volumes during the SARS-CoV-2 epidemic peak in Verona, Italy
por: Merler, S., et al.
Publicado: (2020)

Immunotherapy in malignant pleural mesothelioma: a review of literature data
por: Menis, Jessica, et al.
Publicado: (2021)

Molecular predictors of EGFR-mutant NSCLC transformation into LCNEC after frontline osimertinib: digging under the surface
por: Belluomini, L., et al.
Publicado: (2021)

Plasmacytoid Dendritic Cell, Slan(+)-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients
por: Pettinella, Francesca, et al.
Publicado: (2023)

How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center
por: Pasello, Giulia, et al.
Publicado: (2021)

Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story
por: Piro, Geny, et al.
Publicado: (2019)

The Renaissance of KRAS Targeting in Advanced Non-Small-Cell Lung Cancer: New Opportunities Following Old Failures
por: Ferrara, Miriam Grazia, et al.
Publicado: (2021)

Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer
por: Carbone, Carmine, et al.
Publicado: (2019)

Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients
por: Adamo, Annalisa, et al.
Publicado: (2023)

Bad research is not all bad
por: Hamilton, Fergus, et al.
Publicado: (2023)

Identification of Targetable Liabilities in the Dynamic Metabolic Profile of EGFR-Mutant Lung Adenocarcinoma: Thinking beyond Genomics for Overcoming EGFR TKI Resistance
por: Gkountakos, Anastasios, et al.
Publicado: (2022)

A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC
por: Del Re, Marzia, et al.
Publicado: (2020)

Nonablative radiofrequency in the treatment of refractory vulvar lichen sclerosus: A case series
por: Balbinotti, Rodrigo Rossi, et al.
Publicado: (2021)

Is it really a piece of cake to label Geographical Indications with the Nutri-Score? Consumers’ behaviour and policy implications
por: Stiletto, Alice, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ullqtfiv84n76tg5e9f75lfcn3